logo

2.08

2.08 (-0.11%)

As of Mar 06, 2024

Galectin Therapeutics Inc [GALT]

Source: 

Company Overview

Galectin Therapeutics Inc is a clinical stage biopharmaceutical company engaged in drug research and development to create new therapies for fibrotic disease, cancer and selected other diseases. Our drug candidates are based on our method of targeting galectin proteins, which are key mediators of biologic and pathologic functions.

CountryUnited States
Headquartersnorcrossgeorgia
Phone Number678-620-3186
Industry
manufacturing
CEOJoel Lewis
Websitewww.galectintherapeutics.com